Back to Search Start Over

Leprosy. An Update: Definition, Pathogenesis, Classification, Diagnosis, and Treatment

Authors :
S.E. González González
Jorge Ocampo-Candiani
Julio C. Salas-Alanis
K. Eichelmann
Source :
Actas Dermo-Sifiliográficas (English Edition). 104:554-563
Publication Year :
2013
Publisher :
Elsevier BV, 2013.

Abstract

Leprosy is a chronic granulomatous disease caused by the bacillus Mycobacterium leprae. It primarily affects the skin and peripheral nerves and is still endemic in various regions of the world. Clinical presentation depends on the patient's immune status at the time of infection and during the course of the disease. Leprosy is associated with disability and marginalization. Diagnosis is clinical and is made when the patient has at least 1 of the following cardinal signs specified by the World Health Organization: hypopigmented or erythematous macules with sensory loss; thickened peripheral nerves; or positive acid-fast skin smear or skin biopsy with loss of adnexa at affected sites. Leprosy is treated with a multidrug combination of rifampicin, clofazimine, and dapsone. Two main regimens are used depending on whether the patient has paucibacillary or multibacillary disease.

Details

ISSN :
15782190
Volume :
104
Database :
OpenAIRE
Journal :
Actas Dermo-Sifiliográficas (English Edition)
Accession number :
edsair.doi.dedup.....4f73348f3992e298a08fb35269590baf
Full Text :
https://doi.org/10.1016/j.adengl.2012.03.028